Document Detail


Vascular update: morphogenesis, tumors, malformations, and molecular dimensions.
MedLine Citation:
PMID:  16958055     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This vascular review is organized under the following headings: vasculogenesis and angiogenesis; vascular endothelial growth factors, their receptors, TIE receptors, and angiopoietins; other factors in blood vessel formation; parallel patterning in blood vessels and nerves; physiological and pathological neovascularization; the role of VEGF receptors in metastasis; anti-angiogenic therapy for tumors; association of blood vessels with fat; vascular malformations and vascular tumors; infantile hemangiomas; congenital hemangiomas; lymphatic malformations; molecular characteristics of some disorders with vascular malformations; Kasabach-Merritt phenomenon; Sturge-Weber syndrome, Klippel-Trenaunay syndrome, and Parkes Weber syndrome; diagnostic and laboratory studies; and future perspectives.
Authors:
M Michael Cohen
Related Documents :
9050045 - Sturge-weber syndrome revisited: the role of neuroradiology.
3987735 - Variability in the proteus syndrome: report of an affected child with progressive lipom...
1823885 - A case of mucosal prolapse syndrome.
17645615 - Management of urethral hemangiomas associated with klippel-trenaunay-weber syndrome by ...
7379085 - Superior vena cava syndrome: a new radiologic approach to diagnosis.
21437545 - Do you know this syndrome?
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  American journal of medical genetics. Part A     Volume:  140     ISSN:  1552-4825     ISO Abbreviation:  Am. J. Med. Genet. A     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-09-28     Completed Date:  2006-11-29     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  101235741     Medline TA:  Am J Med Genet A     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2013-38     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Dalhousie University, 5981 University Ave., Halifax, Nova Scotia B3H 1W2. michael.cohen@dal.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiogenesis Inhibitors / therapeutic use
Blood Vessels / abnormalities*,  growth & development*,  physiology
Child
Female
Humans
Lymphatic Vessels / abnormalities
Male
Morphogenesis
Neoplasms, Vascular Tissue / congenital,  drug therapy,  etiology*
Neovascularization, Pathologic
Neovascularization, Physiologic
Receptors, Vascular Endothelial Growth Factor / physiology
Syndrome
Vascular Endothelial Growth Factor A / physiology
Chemical
Reg. No./Substance:
0/Angiogenesis Inhibitors; 0/Vascular Endothelial Growth Factor A; EC 2.7.10.1/Receptors, Vascular Endothelial Growth Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c....
Next Document:  Idiopathic normal pressure hydrocephalus may be a "two hit" disease: benign external hydrocephalus i...